XML 89 R7.htm IDEA: XBRL DOCUMENT v3.23.3Close
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Operating activities:    
Net income/(loss) $ 2,048 $ 1,058
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 836 768
Stock-based compensation 164 116
Deferred taxes (247) (515)
Loss/(gain) on sale of investments 8 (41)
Net losses from and impairment of unconsolidated investees 91 1,152
Other 54 31
Changes in assets and liabilities:    
Customer accounts receivable (112) (72)
Other current and non-current assets (35) (170)
Section 31 fees payable (205) 1
Deferred revenue 127 130
Other current and non-current liabilities (156) 4
Total adjustments 525 1,404
Net cash provided by operating activities 2,573 2,462 Close
Investing activities:    
Capital expenditures (104) (125)
Capitalized software development costs (222) (200)
Purchases of invested margin deposits (1,360) (6,935)
Proceeds from sales of invested margin deposits 3,396 4,285
Cash paid for acquisitions, net of cash acquired (10,247) (57)
Proceeds from sale of/(purchases of) equity and equity method investments   (69)
Proceeds from sale of Euroclear investment 90  
Purchases of investments (956) 0
Other 0 (1)
Net cash used in investing activities (9,403) (2,361) Close
Financing activities:    
Proceeds from/(repayments of) debt facilities, net 514 5,189
Proceeds from/(redemption of) commercial paper, net 2,257 (1,012)
Repurchases of common stock 0 (632)
Dividends to stockholders (713) (640)
Change in cash and cash equivalent margin deposits and guaranty funds (64,729) 13,503
Payments relating to treasury shares received for restricted stock tax payments and stock option exercises (53) (72)
Other 13 37
Net cash (used in)/provided by financing activities (62,711) 16,373 Close
Effect of exchange rate changes on cash, cash equivalents, restricted cash and cash equivalents, and cash and cash equivalent margin deposits and guaranty funds (7) (41) Close
Net (decrease)/increase in cash, cash equivalents, restricted cash and cash equivalents, and cash and cash equivalent margin deposits and guaranty funds (69,548) 16,433 Close
Cash, cash equivalents, restricted cash and cash equivalents, and cash and cash equivalent margin deposits and guaranty funds at beginning of period 150,343 147,976
Cash, cash equivalents, restricted cash and cash equivalents, and cash and cash equivalent margin deposits and guaranty funds at end of period 80,795 164,409
Supplemental cash flow disclosure:    
Cash paid for income taxes 658 710
Cash paid for interest 524 368
Reconciliation of the components of cash, cash equivalents, restricted cash and cash equivalents, and cash and cash equivalent margin deposits and guaranty funds to the balance sheet:    
Cash and cash equivalents 837 1,183
Short-term restricted cash and cash equivalents 471 6,032
Long-term restricted cash and cash equivalents 190 405
Cash and cash equivalent margin deposits and guaranty funds 79,297 156,789
Total 80,795 164,409
Euroclear    
Adjustments to reconcile net income to net cash provided by operating activities:    
Loss/(gain) on sale of investments   (41)
Investing activities:    
Proceeds from sale of Euroclear investment $ 0 $ 741